Among over 1 million men aged 40 or older diagnosed with lower urinary tract symptoms, those treated with tadalafil showed marked reductions in mortality (56%), heart attack (37%), stroke (35%), venous thromboembolism (32%), and dementia (55%) compared to patients who did not receive these medications for lower urinary tract symptoms.
